| Ticker | Inception | CUSIP | Net Expense Ratio1 | Gross Expense Ratio | Current Assets | Minimum Investment | |
|---|---|---|---|---|---|---|---|
| Institutional | CRIMX | January 6, 1998 | 92934R769 | 0.98% | 0.98% | $257 million | $1,000,000 |
| Investor | CRMMX | September 20, 2000 | 92934R777 | 1.15% | 1.15% | $167 million | $2,500 |
¹The net expense ratio for the CRM Mid Cap Value Fund is the ratio listed in the CRM Funds Prospectus, dated October 28, 2022. This figure will fluctuate over time.
CRM Mid Cap Value Fund seeks long-term capital appreciation. The CRM Mid Cap Value Fund, under normal circumstances, invests at least 80% of its assets in a diversified portfolio of equity and equity related securities of companies with market capitalizations at the time of initial purchase similar to those in the Russell Midcap Value Index (“mid cap companies”) that are publicly traded on a U.S. securities market.
The market capitalization range of the Russell Midcap Value Index changes constantly, and as a result, the capitalization of mid cap companies in which the Mid Cap Value Fund will invest will also change. As of September 30 2022, the market capitalization range of the Russell Midcap Value Index was from approximately $271 million to $45 billion.
Supported by an experienced team of investment professionals, the portfolio managers make judgments about the relative attractiveness of various securities in selecting stocks for the Mid Cap Value Mutual Fund. This Fund typically will be invested in 35 to 50 stocks. Although the Fund is built from the bottom up, stock-specific risks, sector weightings and risk/reward characteristics are all taken into account in the portfolio construction process.
As of March 31, 2023
It should not be assumed that the holdings presented have been profitable or will in the future be profitable. Holdings are subject to change at any time without notice.
| ChampionX Corporation | 3.6% |
| Burlington Stores, Inc. | 3.4% |
| Lamb Weston Holdings, Inc. | 3.3% |
| Vontier Corporation | 3.3% |
| Corteva, Inc. | 3.3% |
| Envista Holdings Corporation | 3.2% |
| LKQ Corporation | 3.2% |
| Clarivate PLC | 3.1% |
| Bio-Rad Laboratories, Inc. | 3.0% |
| Ashland, Inc. | 3.0% |
| Total | 32.2% |
As a shareholder of a Fund, you are entitled to dividends and other distributions arising from net investment income and net realized gains, if any, earned on the investments held by the Funds. Dividends and distributions, if any, are declared and paid annually to you. Each Fund expects to distribute any net realized gains once a year.
Distributions are payable to the shareholders of record at the time the distributions are declared (including holders of shares being redeemed, but excluding holders of shares being purchased). All distributions are reinvested in additional Fund shares unless you have elected to receive the distributions in cash.
| Short Term | Long Term | Ordinary Income | Total | |
|---|---|---|---|---|
| Institutional Class | $0.1631 | $0.5278 | $0.2970 | $0.9879 |
| Investor Class | $0.1631 | $0.5278 | $0.2596 | $0.9505 |
As of March 31, 2023
| Year | Mid Cap Value | Russell Midcap Value Index | Russell Midcap Index |
| Q1’23 | 0.92 | 1.32 | 4.06 |
| YTD | 0.92 | 1.32 | 4.06 |
| 1 Yr | -4.91 | -9.22 | -8.78 |
| 3 Yr | 21.31 | 20.69 | 19.20 |
| 5 Yr | 8.65 | 6.54 | 8.05 |
| 10 Yr | 10.24 | 8.80 | 10.05 |
| ICD | 10.90 | 8.91 | 9.10 |
| Year | Mid Cap Value | Russell Midcap Value Index | Russell Midcap Index |
| Q1'23 | 0.88 | 1.32 | 4.06 |
| YTD | 0.88 | 1.32 | 4.06 |
| 1 Yr | -5.09 | -9.22 | -8.78 |
| 3 Yr | 21.09 | 20.69 | 19.20 |
| 5 Yr | 8.44 | 6.54 | 8.05 |
| 10 Yr | 10.03 | 8.80 | 10.05 |
| ICD | 10.04 | 9.45 | 8.38 |
The performance above represent past performance, which does not guarantee future results. If you invest in a Fund, your investment return and principal value will fluctuate, so that your shares, when redeemed, may be worth more of less than their original cost. The Fund’s current performance may be lower or higher than the performance above. For most recent month-end performance, please click here.
Shares of CRM Funds are distributed by ALPS Distributors, Inc.
Cramer Rosenthal McGlynn, LLC is the investment advisor to the CRM Funds and is not affiliated with ALPS.
Principal investment risks: The Fund invests in value stocks which can perform differently from the market on whole and may continue to be undervalued for long periods of time. Compared to mutual funds that focus exclusively on large capitalization companies, shares of the Fund may be more volatile because they invest in mid capitalization companies. Mid capitalization companies are likely to have more limited product lines, fewer capital resources and less depth of management than larger companies.
The Funds are subject to risks, which are described in the prospectus. In particular, when compared to mutual funds that focus on larger capitalization companies, shares of the Funds generally are more volatile because of the exposure to smaller and mid capitalization companies, which may have more limited product lines and fewer capital resources. Value-based investments are subject to the risk that the broad market may not recognize their intrinsic values.
The Russell Midcap Value Index measures the performance of those companies in the Russell Midcap Index with lower price-to-book ratios and lower forecasted growth values. The Russell Midcap Index measures the performance of the 800 smallest companies in the Russell 1000 Index, which represents the performance of the 1,000 largest companies in the U.S. equity market. It is not possible to invest directly in an index.
You should consider the investment objectives, risks, charges and expenses of the Funds carefully before investing. Before making an investment, please download a prospectus containing all the information about the Funds or call 800.276.2883. You should read the prospectus carefully before investing.